One Pathway for Esophageal Cancer? - Summary - MDSpire
From the Journals

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min

Share

A multicenter study involving 3,100 patients across 25 UK centers reveals that esophageal adenocarcinoma (EAC) may develop through a common biological pathway linked to Barrett's esophagus (BE), regardless of detectable BE at diagnosis. Findings show that demographic and risk factors for patients with and without BE are similar, and genomic analyses indicate substantial overlap between tumors in both groups. Key mutations and markers associated with intestinal metaplasia were found in EAC cases lacking identifiable BE, suggesting implication for early detection and stratification strategies.

Original Source(s)

One Pathway for Esophageal Cancer?

  • May 7, 2026

Related Content

Plasma miR-371a-3p Predicts Recurrence in Stage I Testicular Cancer: Interim Results From the CLIMATE Study

In the management of stage I testicular cancer, a persistent clinical dilemma is the identification of patients who truly need adjuvant treatment after orchiectomy rather than active surveillance alon...

‘Promising’ Signal Only: ctDNA in Early Breast Cancer Not Yet Ready for Clinical Use

Despite compelling prognostic associations across multiple retrospective data sets, no interventional trial has demonstrated that acting on circulating tumor DNA testing results in early breast cancer...

Experimental Daraxonrasib Shows Promise in Advanced Pancreatic Cancer

Metastatic pancreatic ductal adenocarcinoma remains one of the most challenging malignancies to treat in clinical oncology.

  • by

  • May 6, 2026

  • 5 min